[Results of a clinical test on the oral antidiabetic agent glibornuride (Ro 6-4563)].
D000328:Adult; D000368:Aged; D000469:Alkaline Phosphatase / Q000097:blood; D001663:Bilirubin / Q000097:blood; D001786:Blood Glucose; D001892:Camphanes / Q000627:therapeutic use; D055598:Chemical Phenomena; D002621:Chemistry; D002784:Cholesterol / Q000097:blood; D002986:Clinical Trials as Topic; D003920:Diabetes Mellitus / Q000188:drug therapy; D005069:Evaluation Studies as Topic; D005260:Female; D006801:Humans; D007004:Hypoglycemic Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D013453:Sulfonylurea Compounds / Q000008:administration & dosage / Q000627:therapeutic use*; D000637:Transaminases / Q000097:blood
D001786:Blood Glucose; D001892:Camphanes; D007004:Hypoglycemic Agents; D013453:Sulfonylurea Compounds; D002784:Cholesterol; D000637:Transaminases; D000469:Alkaline Phosphatase; D001663:Bilirubin
Ergebnisse der klinischen Prüfung des oralen Antidiabetikums Glibornurid (Ro 6-4563.